NYSE:TMOLife Sciences
Thermo Fisher Scientific (TMO) Margin Improvement Challenges Long Term Earnings Decline Narrative
Thermo Fisher Scientific (TMO) closed out FY 2025 with fourth quarter revenue of US$12.2b and basic EPS of US$5.25, alongside net income of US$1.96b, setting a clear benchmark for how the year wrapped up. Over the past six quarters, the company has seen quarterly revenue range from US$10.4b to US$12.2b and basic EPS move between US$3.99 and US$5.25. This gives investors a detailed view of how the top and bottom line have tracked through FY 2024 and FY 2025. With trailing 12 month EPS at...